Category: Artificial Intelligence in Healthcare
We cannot simply accept that testing new drugs will continue to be a slow and expensive process. AI has the potential to disrupt the current approach to clinical trials — from patient recruitment to adherence monitoring and data collection – and it is time to seize these opportunities.
We have an incredible opportunity to further streamline processes and workflows like never before. By incorporating practices driven by analytics and emerging technology, healthcare systems can meet the goal of delivering consistent, quality care.
Which is more important when working with healthcare AI detection: that it never misses something on a patient scan, or that it never identifies something that isn’t there?
Neutralizing the next threat to public health requires a new mindset, a new development path that uses computers and algorithms working in concert with patients, physicians, and scientists.
AI has already shown tremendous promise for everything from automating patient communication and non-clinical administrative tasks to reducing physician burnout. But realizing that promise more broadly requires AI developers to establish trust with their healthcare users.
Just as Amazon leverages machine learning to develop valuable insights into consumer purchasing behavior in real time, healthcare organizations can strengthen their ability to reduce costs of care and eliminate waste and abuse with this type of intelligence.
If we continue to apply the technology without widespread agreement to these basic premises, we could dissolve people’s trust before we even earn it.
Drug discovery is a complex process which involves significant utilization of time and resources. As per several sources, on an average, the entire drug development process (from initial proof-of-concept to commercial launch) takes around 10-15 years and capital investments worth USD 4-10 billion to develop a drug from concept to commercial launch. The early stages […]
What You Should Know: – Nuance acquires ambient AI healthcare voice assistant Saykara, Inc. to bring complementary AI technology and engineering talent to conversational AI and ambient clinical intelligence market leader. – Kara’s AI-powered healthcare voice assistant can be used during a physician-patient encounter without any voice commands, promising to eliminate up to 100% of […]
Artificial Intelligence have demonstrated intelligent behavior through their ability to learn, communicate with its users and solve complex problems using highly sophisticated algorithms. AI-driven technologies have continued to evolve rapidly, with several industries increasingly deploying such solutions across key aspects of value chain. Furthermore, AI is also made with same idea of making tasks simpler […]
In this article, experts forecast upcoming AI developments that will help shape a new commercial model, making 2021 the year when AI shifts from early exploration to broad adoption.
AI models offer an early look into who might develop kidney disease, who would benefit from early intervention, and the risk of further complications without a change in course. However, it is worth taking a close look to ensure any bias or gaps are addressed.
Oncology diagnosis inclusing digital pathology, telehealth and physician access are just some of the areas where AI can have outsize impact in 2021
With a recent acquisition from France, Medtronic is aiming to leverage AI in the world of spine surgery and integrate the system with its robot.
What You Should Know: – Centene Corporation acquires AI healthcare analytics platform Apixio to additional data and AI capability to technology portfolio. – Apixio will remain an operationally independent entity as part of Centene’s Health Care Enterprises group to continue bringing value to its clients and the industry. Centene Corporation, today announced it has signed […]
Front row (left to right): Jian Chen, Vice President, Xian Janssen Pharmaceuticals; Dan Wang, Head, Johnson & Johnson Innovation, Asia Pacific; Sharona Tao, Leader, Communications & Public Affairs, Johnson & Johnson China; Jennifer Yang, Head, Lung Cancer Initiative China, Johnson & Johnson Back row (left to right): Alex Zhavoronkov, Founder & CEO, Insilico Medicine; Li […]
What You Should Know: – Innovaccer launches its artificial intelligence (AI)-enabled patient relationship management solution to streamline communication between patients and their care teams. – The solution enables providers and member teams to move beyond treating illness to facilitating proactive care by building productive, long-term relationships with patients. Innovaccer, Inc., a San Francisco, CA-based healthcare […]